Current Gene Therapy ISSN (Print): 1566-5232 ISSN (Online): 1875-5631
journal

Impact Factor

 3.8

CiteScore

 6.7

Acceptance rate

 37%

Publishing options for this journal

$3633

Article Processing Charges (APC), excluding taxes

Subject area
Genetics & Genomics, Genetics & Heredity, Life Sciences, Molecular Medicine
Journal scope

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Current Medicinal Chemistry ISSN (Print): 0929-8673 ISSN (Online): 1875-533X
journal

Impact Factor

 3.5

CiteScore

 8.6

Acceptance rate

 57%

Publishing options for this journal

$3940

Article Processing Charges (APC), excluding taxes

Subject area
Anti-Infectives and Infectious Diseases, Biochemistry and Molecular Biology, Chemistry, Drug Design & Discovery, Immunology, Inflammation & Allergy, Medicinal Chemistry, Pharmacology
Journal scope

Current Medicinal Chemistry covers all the latest and outstanding developments in the field of medicinal chemistry. It also includes topics related to quantitative structure-function relationships, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, as well as chemical and analytical techniques used in rational drug design. Each issue incorporates a series of timely in-depth/mini-reviews and guest-edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents.

Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important developments relevant to their field.

Mini-Reviews in Medicinal Chemistry ISSN (Print): 1389-5575 ISSN (Online): 1875-5607
journal

Impact Factor

 3.3

CiteScore

 7.8

Acceptance rate

 20%

Publishing options for this journal

$3450

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Pharmaceutical and Medicinal Chemistry, Pharmacology
Journal scope

The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Mini-Reviews in Medicinal Chemistry covers all areas of medicinal chemistry, including quantitative structure-function relationships, synthetic chemistry, bioorganic chemistry, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug safety profile and drug-induced liver injury (DILI), drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, "nanosystem and nanocarriers", as well as chemical and analytical techniques used in rational drug design. 

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to remain  informed and up-to-date with the latest and most important developments.

Current Drug Targets ISSN (Print): 1389-4501 ISSN (Online): 1873-5592
journal

Impact Factor

 3

CiteScore

 6.2

Acceptance rate

 22%

Publishing options for this journal

$2950

Article Processing Charges (APC), excluding taxes

Subject area
Drug Design & Discovery, Pharmacology
Journal scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Topics in Medicinal Chemistry ISSN (Print): 1568-0266 ISSN (Online): 1873-4294
journal

Impact Factor

 2.9

CiteScore

 6.4

Acceptance rate

 57%

Publishing options for this journal

$2950

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Immunology, Inflammation & Allergy, Pharmaceutical and Medicinal Chemistry, Pharmacology
Journal scope

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to in-depth mini-reviews/ research and guest-edited reviews/ research which provide the reader with a comprehensive survey of that respective area. A Guest Editor who is an expert in the topic under review will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. Understanding the relationship between structure and function is crucial to understand the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important advances.

Current Vascular Pharmacology ISSN (Print): 1570-1611 ISSN (Online): 1875-6212
journal

Impact Factor

 2.8

CiteScore

 9.2

Acceptance rate

 27%

Publishing options for this journal

$3450

Article Processing Charges (APC), excluding taxes

Subject area
Cardiology, Peripheral Vascular Disease, Pharmacology
Journal scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Current Drug Delivery ISSN (Print): 1567-2018 ISSN (Online): 1875-5704
journal

Impact Factor

 2.8

CiteScore

 5.1

Acceptance rate

 36%

Publishing options for this journal

$3695

Article Processing Charges (APC), excluding taxes

Subject area
Drug Delivery, Drug Delivery, Drug Design, Discovery and Therapy, Pharmacology
Journal scope

Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.

The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.

The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
CNS & Neurological Disorders - Drug Targets ISSN (Print): 1871-5273 ISSN (Online): 1996-3181
journal

Impact Factor

 2.7

CiteScore

 5.1

Acceptance rate

 26%

Publishing options for this journal

$3645

Article Processing Charges (APC), excluding taxes

Subject area
Neurology, Neurology, Pharmacology
Journal scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Anti-Cancer Agents in Medicinal Chemistry ISSN (Print): 1871-5206 ISSN (Online): 1875-5992
journal

Impact Factor

 2.6

CiteScore

 5.1

Acceptance rate

 42%

Publishing options for this journal

$3645

Article Processing Charges (APC), excluding taxes

Subject area
Chemistry, Drug Design & Discovery, Medicinal Chemistry, Oncology, Pharmacology
Journal scope

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth/mini-reviews and guest-edited issues written by leaders in the field covering a range of current topics in oncology and medicinal chemistry. The journal considers high-quality reviews and research papers for publication. Scientific areas within the scope of the journal include:

●      Medicinal chemistry, prevention, diagnosis, and treatment of malignant diseases
●      In silico studies of drug-target interaction in anti-cancer drug assessment
●      Underlying biology and medicinal chemistry strategies for anti-cancer drug synthesis and development
●      New drugs related to a specific target or target class for anticancer drugs
●      Drug repositioning in cancer
●      Clinical cancer research
●      Radiotherapy and systemic treatment of cancer
●      Other related areas

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

Current Pharmaceutical Design ISSN (Print): 1381-6128 ISSN (Online): 1873-4286
journal

Impact Factor

 2.6

CiteScore

 6.3

Acceptance rate

 36%

Publishing options for this journal

$3425

Article Processing Charges (APC), excluding taxes

Subject area
Immunology, Inflammation & Allergy, Pharmacology
Journal scope

Current Pharmaceutical Design publishes timely in-depth reviews/mini reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

© 2024 Bentham Science Publishers | Privacy Policy